| Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study MLNG Malbrain, D Chiumello, P Pelosi, D Bihari, R Innes, VM Ranieri, ... Critical care medicine 33 (2), 315-322, 2005 | 1105 | 2005 |
| Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis FA Bozza, JI Salluh, AM Japiassu, M Soares, EF Assis, RN Gomes, ... Critical care 11, 1-8, 2007 | 938 | 2007 |
| Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study MLNG Malbrain, D Chiumello, P Pelosi, A Wilmer, N Brienza, V Malcangi, ... Intensive care medicine 30, 822-829, 2004 | 796 | 2004 |
| A central role for free heme in the pathogenesis of severe sepsis R Larsen, R Gozzelino, V Jeney, L Tokaji, FA Bozza, AM Japiassú, ... Science translational medicine 2 (51), 51ra71-51ra71, 2010 | 513 | 2010 |
| The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study FR Machado, AB Cavalcanti, FA Bozza, EM Ferreira, FSA Carrara, ... The Lancet Infectious Diseases 17 (11), 1180-1189, 2017 | 371 | 2017 |
| Sepse Brasil: estudo epidemiológico da sepse em unidades de terapia intensiva brasileiras JAL Sales Júnior, CM David, R Hatum, PCSP Souza, A Japiassú, ... Revista Brasileira de Terapia Intensiva 18, 9-17, 2006 | 339* | 2006 |
| Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis FA Bozza, RN Gomes, AM Japiassú, M Soares, HC Castro-Faria-Neto, ... Shock 22 (4), 309-313, 2004 | 245 | 2004 |
| Organizational characteristics, outcomes, and resource use in 78 Brazilian intensive care units: the ORCHESTRA study M Soares, FA Bozza, DC Angus, AM Japiassú, WN Viana, R Costa, ... Intensive care medicine 41, 2149-2160, 2015 | 169 | 2015 |
| Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5′-triphosphate synthase activity AM Japiassu, APSA Santiago, P Joana da Costa, LF Garcia-Souza, ... Critical care medicine 39 (5), 1056-1063, 2011 | 162 | 2011 |
| Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients AM Japiassú, RT Amâncio, EC Mesquita, DM Medeiros, HB Bernal, ... Critical Care 14, 1-8, 2010 | 133 | 2010 |
| Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis RN Gomes, FA Bozza, RT Amâncio, AM Japiassú, RCS Vianna, ... Shock 26 (1), 41-49, 2006 | 82 | 2006 |
| Epidemiology of sepsis in Brazil: Incidence, lethality, costs, and other indicators for Brazilian Unified Health System hospitalizations from 2006 to 2015 RA Quintano Neira, S Hamacher, AM Japiassu PloS one 13 (4), e0195873, 2018 | 78 | 2018 |
| The challenge of predicting pressure ulcers in critically ill patients. A multicenter cohort study OT Ranzani, ES Simpson, AM Japiassu, DT Noritomi Annals of the American Thoracic Society 13 (10), 1775-1783, 2016 | 72 | 2016 |
| An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil IT Balassiano, J dos Santos-Filho, MPB de Oliveira, MC Ramos, ... Diagnostic microbiology and infectious disease 68 (4), 449-455, 2010 | 57 | 2010 |
| Predictive accuracy of the quick sepsis-related organ failure assessment score in Brazil. A prospective multicenter study FR Machado, AB Cavalcanti, MB Monteiro, JL Sousa, A Bossa, AT Bafi, ... American journal of respiratory and critical care medicine 201 (7), 789-798, 2020 | 50 | 2020 |
| Getting a consensus: advantages and disadvantages of Sepsis 3 in the context of middle-income settings FR Machado, MSC Assunção, AB Cavalcanti, AM Japiassú, LCP Azevedo, ... Revista Brasileira de terapia intensiva 28, 361-365, 2016 | 49 | 2016 |
| Chegando a um consenso: vantagens e desvantagens do Sepsis 3 considerando países de recursos limitados FR Machado, MSC Assunção, AB Cavalcanti, AM Japiassú, LCP Azevedo, ... Revista brasileira de terapia intensiva 28 (4), 361-365, 2016 | 47 | 2016 |
| Comparison of two databases to detect potential drug–drug interactions between prescriptions of HIV/AIDS patients in critical care GV Ramos, L Guaraldo, AM Japiassú, FA Bozza Journal of Clinical Pharmacy and Therapeutics 40 (1), 63-67, 2015 | 46 | 2015 |
| In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: A prospective multicenter study from Brazil H Perazzo, SW Cardoso, MPD Ribeiro, R Moreira, LE Coelho, EM Jalil, ... The Lancet Regional Health–Americas 11, 2022 | 42 | 2022 |
| Highly active antiretroviral therapy for critically ill HIV patients: a systematic review and meta-analysis HB Andrade, CR Shinotsuka, IRF da Silva, CS Donini, H Yeh Li, ... PLoS One 12 (10), e0186968, 2017 | 41 | 2017 |
Fernando A. BozzaSenior Scientist, Oswaldo Cruz Foundation (FIOCRUZ), and IDOR, Rio de Janeiro, Brazil在 ini.fiocruz.br 的电子邮件经过验证
